^“CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin”. Blood107 (1): 373–80. (January 2006). doi:10.1182/blood-2005-03-1014. PMID16189277.
^“CD163: a specific marker of macrophages in paraffin-embedded tissue samples”. American Journal of Clinical Pathology122 (5): 794–801. (November 2004). doi:10.1309/QHD6YFN81KQXUUH6. PMID15491976.
^“Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family”. Biochemical and Biophysical Research Communications256 (1): 110–3. (March 1999). doi:10.1006/bbrc.1999.0294. PMID10066432.
^“Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163”. Journal of Leukocyte Biology88 (6): 1201–5. (December 2010). doi:10.1189/jlb.0410235. PMID20807704.
^“Plasma clearance of hemoglobin and haptoglobin in mice and effect of CD163 gene targeting disruption”. Antioxidants & Redox Signaling18 (17): 2254–63. (June 2013). doi:10.1089/ars.2012.4605. PMID22793784.
“CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma”. The International Journal of Biochemistry & Cell Biology34 (4): 309–14. (April 2002). doi:10.1016/S1357-2725(01)00144-3. PMID11854028.
“Haptoglobin and CD163: captor and receptor gating hemoglobin to macrophage lysosomes”. Redox Report6 (6): 386–8. (2002). doi:10.1179/135100001101536490. PMID11865982.
“CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response”. Annals of Medicine36 (5): 347–54. (2005). doi:10.1080/07853890410033171. PMID15478309.
“Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene138 (1–2): 171–4. (January 1994). doi:10.1016/0378-1119(94)90802-8. PMID8125298.
“A new macrophage differentiation antigen which is a member of the scavenger receptor superfamily”. European Journal of Immunology23 (9): 2320–5. (September 1993). doi:10.1002/eji.1830230940. PMID8370408.
“Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene200 (1–2): 149–56. (October 1997). doi:10.1016/S0378-1119(97)00411-3. PMID9373149.
“Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family”. Biochemical and Biophysical Research Communications256 (1): 110–3. (March 1999). doi:10.1006/bbrc.1999.0294. PMID10066432.
“Genomic organization and chromosomal localization of the human CD163 (M130) gene: a member of the scavenger receptor cysteine-rich superfamily”. Biochemical and Biophysical Research Communications260 (2): 466–74. (July 1999). doi:10.1006/bbrc.1999.0866. PMID10403791.
“Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation”. Journal of Leukocyte Biology66 (5): 858–66. (November 1999). doi:10.1002/jlb.66.5.858. PMID10577520.
“Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli”. Journal of Leukocyte Biology67 (1): 97–103. (January 2000). doi:10.1002/jlb.67.1.97. PMID10648003.
“Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis”. Cytogenetics and Cell Genetics90 (3–4): 246–7. (2001). doi:10.1159/000056781. PMID11124526.
“Development of an ELISA to measure soluble CD163 in biological fluids”. Journal of Immunological Methods252 (1–2): 25–31. (June 2001). doi:10.1016/S0022-1759(01)00328-3. PMID11334962.
“Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation”. Biochemical and Biophysical Research Communications288 (4): 841–3. (November 2001). doi:10.1006/bbrc.2001.5845. PMID11688984.
“Macrophage subpopulations in rheumatoid synovium: reduced CD163 expression in CD4+ T lymphocyte-rich microenvironments”. Arthritis and Rheumatism46 (5): 1210–6. (May 2002). doi:10.1002/art.10207. PMID12115225.
“Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect”. FEBS Letters526 (1–3): 93–6. (August 2002). doi:10.1016/S0014-5793(02)03142-3. PMID12208511.